Collective effort is key to avoiding reproducibility struggles that have plagued many scientific fields
Chemical & Engineering News (C&EN) Homepage
In a recent update to its 2022 PFAS lawsuit against DuPont, Corteva, Chemours, and Qnity Electronics, the state alleges the companies engaged in fraudulent corporate restructuring
A proton NMR puzzle and scientific spelling bee words
Chinese researchers are testing DREADDs, a gene therapy to turn down neuronal activity, in the clinic
But experts say the government needs to extend more support to build a resilient domestic supply chain
A weekly roundup of policy news in the chemical arena and beyond
Test your knowledge of our stories on molecular glues, PVC recycling, biotech, and more
The deal adds Genomatica’s biomanufacturing technology and commercial experience to Again’s carbon-to-chemical platform
After legal challenges from physicians and states stalled past efforts, a new executive order calls for separating combined vaccines and replacing adjuvants
Brain-computer interfaces rely on electrodes to gather enough signal. But the materials and strategies can vary
Scientists have found a way to turn the ubiquitous plastic garbage into high-value lubricants
Researchers demonstrate a molecular coating that can change the stability of a common explosive depending on the light source
The start-up joins the next-generation autoimmune therapy race with $65 million in early funding to move its lead candidate through clinical trials
The moves aim to strengthen both solar and semiconductor supply chains, but experts warn that it may not be enough
---452694:Widescreen?$responsive$&qlt=90,0&resMode=sharp2&fmt=webp&op_sharpen=1)
---452445:Widescreen?$responsive$&qlt=90,0&resMode=sharp2&fmt=webp&op_sharpen=1){kind=spacer}
---444395:Widescreen?$responsive$&qlt=90,0&resMode=sharp2&fmt=webp&op_sharpen=1)
Readers share their picks for overlooked pivotal moments in US chemistry history
This Greening Chemistry column challenges resistance to mechanochemistry’s broader adoption by synthetic chemists
Space is big again. Chemists should jump on the opportunity for exploratory research
Here’s what we’re watching in the chemical and pharmaceutical industries this week
But only a handful of these firms have the capacity to make antibody-drug conjugates start to finish
